Tilray Brands

The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its artificial-intelligence drug design pipeline across multiple therapeutic areas.

Artificial intelligence (AI) is changing the world. Corporations are racing to establish themselves as leaders in the field, while investors want to cash in by putting their hard-earned money into the most promising AI companies.

Goldman Sachs estimates that AI drug discovery and breakthroughs like gene editing will add 0.5% to 2.5% to the U.S. gross domestic product. McKinsey & Co. follows suit, noting AI could generate 30% efficiency gains and cost savings in the pharmaceutical sector and trigger financial gains of up to $110 billion annually.

TCL China Star Optoelectronics Technology, a subsidiary of TCL, is also exhibiting its printing organic light-emitting diode or OLED displays and OLEDs used in smartphone and laptop screens, with sizes ranging from 5.5 inches to 150 inches.

The market's appetite for AI applications in healthcare is rapidly increasing, with TEM emerging as a top contender in this high-growth sector.

Telescope Innovations Corp. (CSE:TELI) is leveraging its expertise to advance chemistry process development and crystallization optimization in pharmaceuticals, industrial chemicals, and critical minerals ・Telescope's Self-Driving Labs (SDLs) integrate AI,

Screen" Trend Continues, Mini LED TV Shipment Further Accelerates, Fully Embracing Intelligent AI Throughout 2024, TCL Electronics continuously capitalised on the global market trends of larger screen sizes and premium features,

In the world of supply chain management, Logility Supply Chain Solutions, Inc. (Nasdaq: LGTY) has long been a trailblazer. Known for its AI-driven technology, the company has revolutionized the way businesses forecast demand,